About: Is adjuvant chemotherapy necessary for patients with ypT0-2N0 rectal cancer treated with neoadjuvant chemoradiotherapy and curative surgery?

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Is adjuvant chemotherapy necessary for patients with ypT0-2N0 rectal cancer treated with neoadjuvant chemoradiotherapy and curative surgery? Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 13 August 2018

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в серпні 2018 (uk) article scientifique publié en 2018 (fr) im August 2018 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'agostu de 2018 (ast) scientific article published on 13 August 2018 (en)
publication date	wds:Q93083821-878BA8EA-6CFA-4141-BD0D-4B3C35B076E3
publication date	2018-08-13 00:00:00Z (xsd:dateTime)
cites work	wds:Q93083821-0DCC5F86-BB70-4CA0-B77F-40558E872AE3 wds:Q93083821-1CECDEA0-A51C-40F4-A566-900220CACF7A wds:Q93083821-214F2D2F-3708-42C4-9D11-F750C34C3C2C wds:Q93083821-2BDADE3E-8A52-4F51-AAB6-B7A421B2FFDD wds:Q93083821-2C3B636C-6879-4723-82D9-F71EA527593C wds:Q93083821-2C415E8D-6E5F-467A-A170-36E1A60B4FF9 wds:Q93083821-2DC45CEA-4D01-4B8F-B3DF-B47ECD6AAE0A wds:Q93083821-4B0C9681-8B5D-4F0B-AFD2-5006A1A40F35 wds:Q93083821-4D17C5BC-C2D6-48FE-8BDD-8650CF47CB42 wds:Q93083821-53578160-B8E8-4695-BF2C-7E3C1CE01EF1 wds:Q93083821-53FB5A18-C06A-4B70-8F62-C26C293F20E0 wds:Q93083821-57EE15E4-DB03-43F6-86A1-ADFB3064C661 wds:Q93083821-6187830C-733D-4DAC-9C41-3E33453B485A wds:Q93083821-64BD6535-7E52-4BAB-BD45-B6DA9696514F wds:Q93083821-798AC6E4-E95A-4AF3-BC9C-6D3F8145C952 wds:Q93083821-8E190FB8-6AA4-4A88-93FA-3CD4D2FD3415 wds:Q93083821-981C74C0-48B1-40E4-8EE6-CFCCBE360EF8 wds:Q93083821-AC302D47-5D17-4F0A-BE94-1C2A7EDF5686 wds:Q93083821-ACFFB520-657B-44E3-8B8F-D32EEF3AA3D7 wds:Q93083821-AD3CF6FC-BB67-4183-A7A6-B4A55908CEA5 wds:Q93083821-B3F42440-303B-4953-BD39-DFD5FD375DFB wds:Q93083821-B5FE138A-2C04-4A3E-873C-11AEA8992E89 wds:Q93083821-C11CD634-3EE0-4996-8F4A-A2EBA890B7F2 wds:Q93083821-C8994C19-205E-481C-9273-70D35AD5A1BB wds:Q93083821-CB456D44-93DA-4F91-8FBD-4C494B1D4252 wds:Q93083821-CF5039D2-BC01-467A-9E88-01521B1FF4BE wds:Q93083821-D48C7D37-9DF0-455D-889B-24E6C9917FFC wds:Q93083821-DB29317A-1863-40AC-88BA-FFA023CC2131 wds:Q93083821-DBCD95A2-09F8-4082-80F9-C9D9A896D1DA wds:Q93083821-E1AEB94B-2D09-49AC-81F6-63C3F5A9F892 wds:Q93083821-E8F8DA56-1EBE-4895-A2D5-FB449930FA3D wds:Q93083821-ED6CEDD7-C5C8-4BDC-BD27-D6AD98D4371D wds:Q93083821-F3C0E508-6928-44F8-9A51-DD6A84473C32
cites work	Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III Adjuvant chemotherapy after preoperative (chemo)radiotherapy and surgery for patients with rectal cancer: a systematic review and meta-analysis of individual patient data Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study A systematic review and meta-analysis of adjuvant chemotherapy after neoadjuvant treatment and surgery for rectal cancer Chronicle: results of a randomised phase III trial in locally advanced rectal cancer after neoadjuvant chemoradiation randomising postoperative adjuvant capecitabine plus oxaliplatin (XELOX) versus control Postoperative chemotherapy after neoadjuvant chemoradiation and surgery for rectal cancer: is it essential for patients with ypT0-2N0? Adjuvant treatment for locally advanced rectal cancer patients after preoperative chemoradiotherapy: when, and for whom? Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial No benefit of adjuvant Fluorouracil Leucovorin chemotherapy after neoadjuvant chemoradiotherapy in locally advanced cancer of the rectum (LARC): Long term results of a randomized trial (I-CNR-RT) Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy? Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defi Pathologic stage is most prognostic of disease-free survival in locally advanced rectal cancer patients after preoperative chemoradiation Capecitabine as adjuvant treatment for stage III colon cancer Pathologic nodal classification is the most discriminating prognostic factor for disease-free survival in rectal cancer patients treated with preoperative chemoradiotherapy and curative resection. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial Neoadjuvant therapy in rectal cancer Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial. Chemoradiation, surgery and adjuvant chemotherapy versus induction chemotherapy followed by chemoradiation and surgery: long-term results of the Spanish GCR-3 phase II randomized trial†. The Efficacy of Adjuvant Chemotherapy in Patients With Stage II/III Resected Rectal Cancer Treated With Neoadjuvant Chemoradiation Therapy Defunctioning Ileostomy Reversal Rates and Reasons for Delayed Reversal: Does Delay Impact on Complications of Ileostomy Reversal? A Study of 170 Defunctioning Ileostomies Role of Adjuvant Chemotherapy in ypT0-2N0 Patients Treated with Preoperative Chemoradiation Therapy and Radical Resection for Rectal Cancer Rectal cancer patients after neoadjuvant radiotherapy (30Gy/10f) with negative lymph node may not benefit from postoperative adjuvant chemotherapy: a retrospective study Recurrence rates and prognostic factors in ypN0 rectal cancer after neoadjuvant chemoradiation and total mesorectal excision. Oncologic results and prognostic predictors of patients with locally advanced rectal cancer showing ypN0 after radical surgery following neoadjuvant chemoradiotherapy. Is adjuvant chemotherapy necessary for patients with pathological complete response after neoadjuvant chemoradiotherapy and radical surgery in locally advanced rectal cancer? Long-term analysis of 40 ypCR patients at a single center. Impact of adjuvant chemotherapy after neoadjuvant radio- or radiochemotherapy for patients with locally advanced rectal cancer. Is routine use of adjuvant chemotherapy for rectal cancer with complete pathological response justified? Is there a role for adjuvant chemotherapy in pathological complete response rectal cancer tumors following neoadjuvant chemoradiotherapy? The survival impact of delayed surgery and adjuvant chemotherapy on stage II/III rectal cancer with pathological complete response after neoadjuvant chemoradiation. Adjuvant chemotherapy after neoadjuvant chemoradiation and curative resection for rectal cancer: is it necessary for all patients?
author name string	wds:Q93083821-3825C810-3DFE-4609-B25F-BAD961A75F12 wds:Q93083821-6773474C-D6A9-4A6C-AFC6-0E349DF6E383 wds:Q93083821-74BA545A-69BE-4FF0-9BF0-EA1DC15F0B50 wds:Q93083821-7CE0C0E1-104F-48E7-AB47-6F160244050C wds:Q93083821-FF4A8A07-B06E-4D38-84E9-B3E31D13E67D
author name string	Zhao Lu Pu Cheng Xi-Shan Wang Ming-Guang Zhang Zhao-Xu Zheng
rdfs:label	Is adjuvant chemotherapy necessary for patients with ypT0-2N0 rectal cancer treated with neoadjuvant chemoradiotherapy and curative surgery? (en) Is adjuvant chemotherapy necessary for patients with ypT0-2N0 rectal cancer treated with neoadjuvant chemoradiotherapy and curative surgery? (nl)
skos:prefLabel	Is adjuvant chemotherapy necessary for patients with ypT0-2N0 rectal cancer treated with neoadjuvant chemoradiotherapy and curative surgery? (en) Is adjuvant chemotherapy necessary for patients with ypT0-2N0 rectal cancer treated with neoadjuvant chemoradiotherapy and curative surgery? (nl)
name	Is adjuvant chemotherapy necessary for patients with ypT0-2N0 rectal cancer treated with neoadjuvant chemoradiotherapy and curative surgery? (en) Is adjuvant chemotherapy necessary for patients with ypT0-2N0 rectal cancer treated with neoadjuvant chemoradiotherapy and curative surgery? (nl)
title	wds:Q93083821-00371713-EAC7-4EA7-B3D3-EE15FA2E121B
title	Is adjuvant chemotherapy necessary for patients with ypT0-2N0 rectal cancer treated with neoadjuvant chemoradiotherapy and curative surgery? (en)
page(s)	wds:Q93083821-DAA70A9A-8A3B-42B0-945E-A49F693B690B
page(s)	277-283
instance of	wds:Q93083821-886035FB-4618-43D8-90DC-838AE0F32251
instance of	scholarly article
PubMed ID	wds:Q93083821-25A5BF6A-C4C5-4147-907D-0215D565BDC7
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/30430016
PubMed ID	30430016

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software